Defence Therapeutics Inc. is a Canadian biotechnology company making significant strides in developing innovative therapies for cancer and immune system-related conditions.

Defence Therapeutics Inc. has established its first U.S. laboratory in the Boston-Cambridge biotech hub, marking a strategic expansion into the U.S. market and enhancing its capabilities in developing innovative therapies for diseases such as cancer.